Eli Lilly is launching LillyDirect to deliver Mounjaro straight to Australian patients’ doors — and local doctors and ...

Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...

Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...

The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress toward other administration priorities in the 2026 fiscal year.

The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.

News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the ...

The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of ...

Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.

Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.

Lizzy led STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

DHS has appealed a court ruling blocking it from restricting how long international students and postdoctoral researchers can ...

The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to ...